NCT04603690View on ClinicalTrials.gov

Oral Curcumin, Quercetin and Vitamin D3 Supplements for Mild to Moderate Symptoms of COVID-19

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

January 31, 2022

Study Completion Date

February 28, 2022

Conditions
Covid-19
Interventions
DIETARY_SUPPLEMENT

Complementary therapy

A daily supplementation of 168 mg curcumin, 260 mg quercetin and 360 IU of vitamin D3 (cholecalciferol) for 14-days

DRUG

Standard of care

This arm will receive standard of care as per the hospital guidelines

Trial Locations (1)

76090

Liaquat University Hospital, Jāmshoro

All Listed Sponsors
lead

Liaquat University of Medical & Health Sciences

OTHER

NCT04603690 - Oral Curcumin, Quercetin and Vitamin D3 Supplements for Mild to Moderate Symptoms of COVID-19 | Biotech Hunter | Biotech Hunter